Biocon Limited (BOM:532523)
India flag India · Delayed Price · Currency is INR
414.05
+1.95 (0.47%)
At close: Aug 21, 2026

Biocon Balance Sheet

Millions INR. Fiscal year is Apr - Mar.

Assets

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Jun '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Cash & Equivalents
-24,16532,27112,33613,2356,630
Short-Term Investments
-7,7688,90710,24819,58520,501
Trading Asset Securities
-6,8984,4733,1564,4432,518
Cash & Short-Term Investments
38,83138,83145,65125,74037,26329,649
Cash Growth
-14.94%-14.94%77.35%-30.92%25.68%-8.03%
Accounts Receivable
-59,86854,87962,30635,73220,582
Other Receivables
-1,5509643891,3214,506
Receivables
-61,41855,84362,69537,05325,759
Inventory
-60,85749,31149,43942,43722,982
Prepaid Expenses
-2,4241,8991,5711,316873
Other Current Assets
-8,26810,15812,3475,2714,560
Total Current Assets
-171,798162,862151,792123,34083,823
Property, Plant & Equipment
-146,635134,141119,778101,22693,643
Long-Term Investments
-13,6476,8156,8438,6733,702
Goodwill
-183,775167,857163,724161,362264
Other Intangible Assets
-104,316102,719102,867105,25912,887
Long-Term Deferred Tax Assets
-5,5562,5773,1733,0102,933
Other Long-Term Assets
-10,77911,00212,53017,5586,688
Total Assets
-636,506587,973560,707520,428203,940

Liabilities

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Jun '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Accounts Payable
-67,72165,48762,72038,42016,085
Accrued Expenses
-11,8559,1312,9064,8401,741
Short-Term Debt
-40,78453,50127,97224,8028,962
Current Portion of Long-Term Debt
-----95
Current Portion of Leases
-724674547390211
Current Income Taxes Payable
-4,1601,7312,7692,2501,618
Current Unearned Revenue
-1,2771,4521,1761,9151,053
Other Current Liabilities
-14,17111,36255,49812,4908,515
Total Current Liabilities
-140,692143,338153,58885,10738,280
Long-Term Debt
-107,463124,054129,324152,90539,985
Long-Term Leases
-5,3705,3914,9242,0912,215
Long-Term Unearned Revenue
-4,8133,3663,1072,90112,151
Pension & Post-Retirement Benefits
-1,6091,2141,1011,034917
Long-Term Deferred Tax Liabilities
-2,4173,5773,9153,818523
Other Long-Term Liabilities
-7,92729,90812,00047,68415,169
Total Liabilities
-270,291310,848307,959295,540109,240

Shareholders' Equity

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Jun '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Common Stock
-8,1056,0036,0036,0036,003
Additional Paid-In Capital
-155,6002,5812,2851,7351,192
Retained Earnings
-141,798191,469177,906162,47669,890
Treasury Stock
--423-784-971-971-324
Comprehensive Income & Other
-35,23817,17112,6149,4267,564
Total Common Equity
340,318340,318216,440197,837178,66984,325
Minority Interest
-25,89760,68554,91146,21910,375
Shareholders' Equity
366,215366,215277,125252,748224,88894,700
Total Liabilities & Equity
-636,506587,973560,707520,428203,940

Additional Metrics

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Jun '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Total Debt
154,341154,341183,620162,767180,18851,468
Net Cash (Debt)
-115,510-115,510-137,969-137,027-142,925-21,819
Net Cash Growth
------
Net Cash Per Share
-78.47-84.40-115.15-114.49-119.51-18.24
Filing Date Shares Outstanding
1,6221,6201,1981,1971,1941,193
Total Common Shares Outstanding
1,6221,6201,1981,1971,1941,193
Working Capital
-31,10619,524-1,79638,23345,543
Book Value Per Share
210.14210.14180.66165.30149.6470.68
Tangible Book Value
52,22752,227-54,136-68,754-87,95271,174
Tangible Book Value Per Share
32.2532.25-45.19-57.45-73.6659.66
Land
-3,9033,7263,3732,9182,805
Buildings
-29,90026,49223,17020,81419,766
Machinery
-135,080120,289103,38997,26276,553
Construction In Progress
-46,12741,01739,85225,87534,203
Leasehold Improvements
-4,1583,6192,6862,518116